Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

NCT04172532 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

92

Enrollment

NIH

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
RADIATION: Hypofractionated Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging
DRUG: Peposertib
OTHER: Placebo Administration

Sponsor

National Cancer Institute (NCI)